Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.

ABSTRACT: The recent covid crisis has provided important lessons for academia and industry regarding digital reorganization. Among the fascinating lessons from these times is the huge potential of data analytics and artificial intelligence. The crisis exponentially accelerated the adoption of analytics and artificial intelligence, and this momentum is predicted to continue into the 2020s and beyond. Drug development is a costly and time-consuming business, and only a minority of approved drugs generate returns exceeding the research and development costs. As a result, there is a huge drive to make drug discovery cheaper and faster. With modern algorithms and hardware, it is not too surprising that the new technologies of artificial intelligence and other computational simulation tools can help drug

SUBMITTER: Floresta G 

PROVIDER: S-EPMC8949797 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature